NCT03508570 2025-05-22Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal CarcinomatosisM.D. Anderson Cancer CenterPhase 1 Completed26 enrolled